Virological and immunological mechanisms in the pathogenesis of human T-cell leukemia virus type 1

Reviews in Medical Virology

Volumn 23, Issue 5, 2013, Pages 269-280

  Satou, Yorifumi ^a,b,c   Matsuoka, Masao ^a  

^a KYOTO UNIVERSITY   (Japan)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIGEN;

ANTIGEN EXPRESSION; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CHRONIC INFLAMMATION; HOMEOSTASIS; HOST CELL; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE RESPONSE; IMMUNOLOGICAL PARAMETERS; LEUKEMOGENESIS; NONHUMAN; PATHOGENESIS; PROVIRUS; REVIEW; T CELL LEUKEMIA; TRANSCRIPTION REGULATION; VIROLOGY; VIRUS REPLICATION;

EID: 84882708286     PISSN: 10529276     EISSN: 10991654     Source Type: Journal    
DOI: 10.1002/rmv.1745     Document Type: Review

References (98)

1. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, et al. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005; 24: 6058-6068.
2. Uchiyama T, Yodoi J, Sagawa K, et al. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977; 50: 481-492.
3. Poiesz BJ, Ruscetti FW, Gazdar AF, et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America 1980; 77: 7415-7419.
4. Miyoshi I, Kubonishi I, Yoshimoto S, et al. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 1981; 294: 770-771.
5. Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986; 1: 1031-1032.
6. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2: 407-410.
7. Mochizuki M, Yamaguchi K, Takatsuki K, et al. HTLV-I and uveitis. Lancet 1992; 339: 1110.
8. Sugimoto M, Nakashima H, Watanabe S, et al. T-lymphocyte alveolitis in HTLV-I-associated myelopathy. Lancet 1987; 2: 1220.
9. Seiki M, Hattori S, Hirayama Y, et al. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proceedings of the National Academy of Sciences of the United States of America 1983; 80: 3618-3622.
10. Yamaoka S, Courtois G, Bessia C, et al. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 1998; 93: 1231-1240.
11. Jin DY, Spencer F, Jeang KT. Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell 1998; 93: 81-91.
12. Igakura T, Stinchcombe JC, Goon PK, et al. Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science 2003; 299: 1713-1716.
13. Pais-Correia AM, Sachse M, Guadagnini S, et al. Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses. Nature Medicine 2010; 16: 83-89.
14. Yoshida M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annual Review of Immunology 2001; 19: 475-496.
15. Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nature Reviews. Cancer 2007; 7: 270-280.
16. Etoh K, Tamiya S, Yamaguchi K, et al. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. Cancer Research 1997; 57: 4862-4867.
17. Cavrois M, Leclercq I, Gout O, et al. Persistent oligoclonal expansion of human T-cell leukemia virus type 1-infected circulating cells in patients with tropical spastic paraparesis/HTLV-1 associated myelopathy. Oncogene 1998; 17: 77-82.
18. Macchi B, Balestrieri E, Ascolani A, et al. Susceptibility of primary HTLV-1 isolates from patients with HTLV-1-associated myelopathy to reverse transcriptase inhibitors. Viruses 2011; 3: 469-483.
19. Kannagi M, Ohashi T, Harashima N, et al. Immunological risks of adult T-cell leukemia at primary HTLV-I infection. Trends in Microbiology 2004; 12: 346-352.
20. Bangham CR, Meekings K, Toulza F, et al. The immune control of HTLV-1 infection: selection forces and dynamics. Frontiers in Bioscience 2009; 14: 2889-2903.
21. Jeffery KJ, Usuku K, Hall SE, et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proceedings of the National Academy of Sciences of the United States of America 1999; 96: 3848-3853.
22. Seich Al Basatena NK, Macnamara A, Vine AM, et al. KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection. PLoS Pathogens 2011; 7: e1002270.
23. Jacobson S, Shida H, McFarlin DE, et al. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 1990; 348: 245-248.
24. Kannagi M, Harada S, Maruyama I, et al. Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. International Immunology 1991; 3: 761-767.
25. Bangham CR, Osame M. Cellular immune response to HTLV-1. Oncogene 2005; 24: 6035-6046.
26. Macnamara A, Rowan A, Hilburn S, et al. HLA class I binding of HBZ determines outcome in HTLV-1 infection. PLoS Pathogens 2010; 6.
27. Banerjee P, Tripp A, Lairmore MD, et al. Adult T-cell leukemia/lymphoma development in HTLV-1-infected humanized SCID mice. Blood 2010; 115: 2640-2648.
28. Villaudy J, Wencker M, Gadot N, et al. HTLV-1 propels thymic human T cell development in "human immune system" Rag2(-)/(-) gamma c(-)/(-) mice. PLoS Pathogens 2011; 7: e1002231.
29. Kawano N, Shimoda K, Ishikawa F, et al. Adult T-cell leukemia development from a human T-cell leukemia virus type I carrier after a living-donor liver transplantation. Transplantation 2006; 82: 840-843.
30. Grassmann R, Aboud M, Jeang KT: Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 2005; 24: 5976-5985.
31. Hall WW, Fujii M. Deregulation of cell-signaling pathways in HTLV-1 infection. Oncogene 2005; 24: 5965-5975.
32. Fujisawa J, Seiki M, Kiyokawa T, et al. Functional activation of the long terminal repeat of human T-cell leukemia virus type I by a trans-acting factor. Proceedings of the National Academy of Sciences of the United States of America 1985; 82: 2277-2281.
33. Yoshida M, Satou Y, Yasunaga J, et al. Transcriptional control of spliced and unspliced human T-cell leukemia virus type 1 bZIP factor (HBZ) gene. Journal of Virology 2008; 82: 9359-9368.
34. Shimotohno K, Takano M, Teruuchi T, et al. Requirement of multiple copies of a 21-nucleotide sequence in the U3 regions of human T-cell leukemia virus type I and type II long terminal repeats for trans-acting activation of transcription. Proceedings of the National Academy of Sciences of the United States of America 1986; 83: 8112-8116.
35. Smith MR, Greene WC. Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes. Genes & Development 1990; 4: 1875-1885.
36. Gillet NA, Malani N, Melamed A, et al. The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood 2011; 117: 3113-3122.
37. Doi K, Wu X, Taniguchi Y, et al. Preferential selection of human T-cell leukemia virus type I provirus integration sites in leukemic versus carrier states. Blood 2005; 106: 1048-1053.
38. Richardson JH, Edwards AJ, Cruickshank JK, et al. In vivo cellular tropism of human T-cell leukemia virus type 1. Journal of Virology 1990; 64: 5682-5687.
39. Yasunaga J, Sakai T, Nosaka K, et al. Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state. Blood 2001; 97: 3177-3183.
40. Satou Y, Utsunomiya A, Tanabe J, et al. HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals. Retrovirology 2012; 9: 46.
41. Nejmeddine M, Negi VS, Mukherjee S, et al. HTLV-1-Tax and ICAM-1 act on T-cell signal pathways to polarize the microtubule-organizing center at the virological synapse. Blood 2009; 114: 1016-1025.
42. Shimizu Y, van Seventer GA, Horgan KJ, et al. Roles of adhesion molecules in T-cell recognition: fundamental similarities between four integrins on resting human T cells (LFA-1, VLA-4, VLA-5, VLA-6) in expression, binding, and costimulation. Immunological Reviews 1990; 114: 109-143.
43. Macallan DC, Wallace D, Zhang Y, et al. Rapid turnover of effector-memory CD4(+) T cells in healthy humans. The Journal of Experimental Medicine 2004; 200: 255-260.
44. Satou Y, Yasunaga J, Zhao T, et al. HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathogens 2011; 7: e1001274.
45. Brown DA, Nelson FB, Reinherz EL, et al. The human interferon-gamma gene contains an inducible promoter that can be transactivated by tax I and II. European Journal of Immunology 1991; 21: 1879-1885.
46. Wano Y, Feinberg M, Hosking JB, et al. Stable expression of the tax gene of type I human T-cell leukemia virus in human T cells activates specific cellular genes involved in growth. Proceedings of the National Academy of Sciences of the United States of America 1988; 85: 9733-9737.
47. Sugata K, Satou Y, Yasunaga J, et al. HTLV-1 bZIP factor impairs cell-mediated immunity by suppressing production of Th1 cytokines. Blood 2012; 119: 434-444.
48. Sakaguchi S, Yamaguchi T, Nomura T, et al. Regulatory T cells and immune tolerance. Cell 2008; 133: 775-787.
49. Belkaid Y. Regulatory T cells and infection: a dangerous necessity. Nature Reviews Immunology 2007; 7: 875-888.
50. Toulza F, Heaps A, Tanaka Y, et al. High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response. Blood 2008; 111: 5047-5053.
51. Yamazaki S, Steinman RM. Dendritic cells as controllers of antigen-specific Foxp3+ regulatory T cells. Journal of Dermatological Science 2009; 54: 69-75.
52. Macatonia SE, Cruickshank JK, Rudge P, et al. Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation. AIDS Research and Human Retroviruses 1992; 8: 1699-1706.
53. Makino M, Shimokubo S, Wakamatsu SI, et al. The role of human T-lymphotropic virus type 1 (HTLV-1)-infected dendritic cells in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis. Journal of Virology 1999; 73: 4575-4581.
54. Jones KS, Petrow-Sadowski C, Huang YK, et al. Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells. Nature Medicine 2008; 14: 429-436.
55. Zhao T, Satou Y, Sugata K, et al. HTLV-1 bZIP factor enhances TGF-{beta} signaling through p300 coactivator. Blood 2011; 118: 1865-1876.
56. Chen W, Jin W, Hardegen N, et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. The Journal of Experimental Medicine 2003; 198: 1875-1886.
57. Vukmanovic-Stejic M, Zhang Y, Cook JE, et al. Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. The Journal of Clinical Investigation 2006; 116: 2423-2433.
58. Satou Y, Yasunaga J, Yoshida M, et al. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proceedings of the National Academy of Sciences of the United States of America 2006; 103: 720-725.
59. Arnold J, Yamamoto B, Li M, et al. Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1. Blood 2006; 107: 3976-3982.
60. Valeri VW, Hryniewicz A, Andresen V, et al. Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits. Blood 2010; 116: 3809-3817.
61. Grossman WJ, Kimata JT, Wong FH, et al. Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proceedings of the National Academy of Sciences of the United States of America 1995; 92: 1057-1061.
62. Hasegawa H, Sawa H, Lewis MJ, et al. Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nature Medicine 2006; 12: 466-472.
63. Giam CZ, Jeang KT. HTLV-1 Tax and adult T-cell leukemia. Frontiers in Bioscience 2007; 12: 1496-1507.
64. Arnold J, Zimmerman B, Li M, et al. Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. Blood 2008; 112: 3788-3797.
65. Usui T, Yanagihara K, Tsukasaki K, et al. Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells. Retrovirology 2008; 5: 34.
66. Karube K, Ohshima K, Tsuchiya T, et al. Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells. British Journal of Haematology 2004; 126: 81-84.
67. Yano H, Ishida T, Inagaki A, et al. Regulatory T-cell function of adult T-cell leukemia/lymphoma cells. International Journal of Cancer 2007, 120: 2052-2057.
68. Chen S, Ishii N, Ine S, et al. Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells. International Immunology 2006; 18: 269-277.
69. Shimauchi T, Kabashima K, Tokura Y: Adult T-cell leukemia/lymphoma cells from blood and skin tumors express cytotoxic T lymphocyte-associated antigen-4 and Foxp3 but lack suppressor activity toward autologous CD8+ T cells. Cancer Science 2008; 99: 98-106.
70. Toulza F, Nosaka K, Takiguchi M, et al. FoxP3+ regulatory T cells are distinct from leukemia cells in HTLV-1-associated adult T-cell leukemia. International Journal of Cancer 2009; 125: 2375-2382.
71. Wildin RS, Ramsdell F, Peake J, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nature Genetics 2001; 27: 18-20.
72. Bennett CL, Christie J, Ramsdell F, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nature Genetics 2001; 27: 20-21.
73. Brunkow ME, Jeffery EW, Hjerrild KA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nature Genetics 2001; 27: 68-73.
74. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057-1061.
75. Miyao T, Floess S, Setoguchi R, et al. Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 2012; 36: 262-275.
76. Miyara M, Yoshioka Y, Kitoh A, et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009; 30: 899-911.
77. Saito M, Matsuzaki T, Satou Y, et al. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). Retrovirology 2009; 6: 19.
78. Tsukasaki K, Hermine O, Bazarbachi A, et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. Journal of Clinical Oncology 2009; 27: 453-459.
79. Utsunomiya A, Miyazaki Y, Takatsuka Y, et al. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation 2001; 27: 15-20.
80. Ishida T, Joh T, Uike N, et al. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. Journal of Clinical Oncology 2012; 30: 837-842.
81. Bazarbachi A, Plumelle Y, Carlos Ramos J, et al. Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes. Journal of Clinical Oncology 2010; 28: 4177-4183.
82. Nishikawa H, Maeda Y, Ishida T, et al. Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma. Blood 2012; 119: 3097-3104.
83. Pancewicz J, Taylor JM, Datta A, et al. Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia. Proceedings of the National Academy of Sciences of the United States of America 2010; 107: 16619-16624.
84. Tamiya S, Etoh K, Suzushima H, et al. Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells. Blood 1998; 91: 3935-3942.
85. Nagai H, Kinoshita T, Imamura J, et al. Genetic alteration of p53 in some patients with adult T-cell leukemia. Japanese Journal of Cancer Research 1991; 82: 1421-1427.
86. Sakashita A, Hattori T, Miller CW, et al. Mutations of the p53 gene in adult T-cell leukemia. Blood 1992; 79: 477-480.
87. Nosaka K, Maeda M, Tamiya S, et al. Increasing methylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia. Cancer Research 2000; 60: 1043-1048.
88. Sasaki H, Nishikata I, Shiraga T, et al. Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia. Blood 2005; 105: 1204-1213.
89. Watanabe M, Nakahata S, Hamasaki M, et al. Downregulation of CDKN1A in adult T-cell leukemia/lymphoma despite overexpression of CDKN1A in human T-lymphotropic virus 1-infected cell lines. Journal of Virology 2010; 84: 6966-6977.
90. Bellon M, Lepelletier Y, Hermine O, et al. Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia. Blood 2009; 113: 4914-4917.
91. Yeung ML, Yasunaga J, Bennasser Y, et al. Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1. Cancer Research 2008; 68: 8976-8985.
92. Yamagishi M, Nakano K, Miyake A, et al. Polycomb-mediated loss of miR-31 activates NIK-dependent NF-kappaB pathway in adult T cell leukemia and other cancers. Cancer Cell 2012; 21: 121-135.
93. Furukawa Y, Tara M, Izumo S, et al. HTLV-I viral escape and host genetic changes in the development of adult T cell leukemia. International Journal of Cancer 2006; 118: 381-387.
94. Yasunaga J, Taniguchi Y, Nosaka K, et al. Identification of aberrantly methylated genes in association with adult T-cell leukemia. Cancer Research 2004; 64: 6002-6009.
95. Yoshida M, Nosaka K, Yasunaga J, et al. Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells. Blood 2004; 103: 2753-2760.
96. Oshiro A, Tagawa H, Ohshima K, et al. Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia/lymphoma. Blood 2006; 107: 4500-4507.
97. Nakahata S, Saito Y, Hamasaki M, et al. Alteration of enhancer of polycomb 1 at 10p11.2 is one of the genetic events leading to development of adult T-cell leukemia/lymphoma. Genes, Chromosomes & Cancer 2009; 48: 768-776.
98. Hidaka T, Nakahata S, Hatakeyama K, et al. Down-regulation of TCF8 is involved in the leukemogenesis of adult T-cell leukemia/lymphoma. Blood 2008; 112: 383-393.